Want to see LFMD full AI Analyst Report?
Total Valuation
LifeMD has a market cap or net worth of $102.19M. The enterprise value is $178.24M.
Market Cap$102.19M
Enterprise Value$178.24M
Share Statistics
LifeMD has 48,200,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,200,836
Owned by Insiders4.54%
Owned by Institutions0.67%
Financial Efficiency
LifeMD’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -26.02%.
Return on Equity (ROE)-0.31
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-26.02%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee554.44K
Profits Per Employee44.63K
Employee Count350
Asset Turnover2.76
Inventory Turnover14.17
Valuation Ratios
The current PE Ratio of LifeMD is ―. LifeMD’s PEG ratio is 0.26.
PE Ratio―
PS Ratio0.79
PB Ratio6.65
Price to FCF-124.26
Price to Operating Cash Flow-10.75
PEG Ratio0.26
Income Statement
In the last 12 months, LifeMD had revenue of 194.06M and earned -7.11M in profits. Earnings per share was -0.23.
Revenue194.06M
Gross Profit154.76M
Operating Income-7.67M
Pretax Income-10.19M
Net Income-7.11M
EBITDA-1.52M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was -9.91M and capital expenditures 2.72M, giving a free cash flow of -7.19M billion.
Operating Cash Flow-9.91M
Free Cash Flow-7.19M
Free Cash Flow per Share-0.15
Dividends & Yields
LifeMD pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.49
52-Week Price Change-65.36%
50-Day Moving Average2.88
200-Day Moving Average3.69
Relative Strength Index (RSI)26.04
Average Volume (3m)702.64K
Important Dates
LifeMD upcoming earnings date is Nov 9, 2026, Before Open (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 9, 2026
Ex-Dividend Date―
Financial Position
LifeMD as a current ratio of 1.25, with Debt / Equity ratio of 75.53%
Current Ratio1.25
Quick Ratio1.18
Debt to Market Cap0.00
Net Debt to EBITDA20.08
Interest Coverage Ratio-5.64
Taxes
In the past 12 months, LifeMD has paid 45.72K in taxes.
Income Tax45.72K
Effective Tax Rate>-0.01
Enterprise Valuation
LifeMD EV to EBITDA ratio is -81.36, with an EV/FCF ratio of -99.66.
EV to Sales0.64
EV to EBITDA-81.36
EV to Free Cash Flow-99.66
EV to Operating Cash Flow14.91
Balance Sheet
LifeMD has $25.14M in cash and marketable securities with $6.02M in debt, giving a net cash position of $19.12M billion.
Cash & Marketable Securities$25.14M
Total Debt$6.02M
Net Cash$19.12M
Net Cash Per Share$0.40
Tangible Book Value Per Share$0.51
Margins
Gross margin is 85.91%, with operating margin of -3.95%, and net profit margin of -3.66%.
Gross Margin85.91%
Operating Margin-3.95%
Pretax Margin-5.25%
Net Profit Margin-3.66%
EBITDA Margin-0.78%
EBIT Margin-4.55%
Analyst Forecast
The average price target for LifeMD is $8.29, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$8.29
Price Target Upside154.95% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-16.73%
EPS Growth Forecast-143.95%